Tower Research Capital (TRC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-660
Closed 6780
2022
Q4
$0 Sell
660
-10,029
-94% ﹤0.01% 6775
2022
Q3
$13K Sell
10,689
-8,239
-44% -$10K ﹤0.01% 4314
2022
Q2
$35K Sell
18,928
-97,743
-84% -$181K ﹤0.01% 3235
2022
Q1
$236K Buy
116,671
+66,419
+132% +$134K ﹤0.01% 1614
2021
Q4
$136K Sell
50,252
-8,327
-14% -$22.5K ﹤0.01% 2037
2021
Q3
$262K Buy
58,579
+42,653
+268% +$191K 0.01% 1561
2021
Q2
$92K Buy
15,926
+10,840
+213% +$62.6K ﹤0.01% 2501
2021
Q1
$36K Sell
5,086
-4,436
-47% -$31.4K ﹤0.01% 3409
2020
Q4
$46K Sell
9,522
-99,219
-91% -$479K ﹤0.01% 3202
2020
Q3
$634K Buy
108,741
+60,152
+124% +$351K 0.01% 1420
2020
Q2
$328K Buy
+48,589
New +$328K 0.01% 1368
2020
Q1
Sell
-222
Closed -$2K 4210
2019
Q4
$2K Sell
222
-299
-57% -$2.69K ﹤0.01% 3155
2019
Q3
$2K Buy
521
+384
+280% +$1.47K ﹤0.01% 3775
2019
Q2
$2K Sell
137
-480
-78% -$7.01K ﹤0.01% 3353
2019
Q1
$15K Buy
617
+517
+517% +$12.6K ﹤0.01% 2457
2018
Q4
$2K Buy
+100
New +$2K ﹤0.01% 3475
2018
Q2
Sell
-48
Closed -$3K 4224
2018
Q1
$3K Sell
48
-583
-92% -$36.4K ﹤0.01% 2895
2017
Q4
$43K Sell
631
-2,372
-79% -$162K 0.01% 1448
2017
Q3
$248K Buy
+3,003
New +$248K 0.02% 609
2017
Q2
Sell
-93
Closed -$6K 3779
2017
Q1
$6K Sell
93
-4,400
-98% -$284K ﹤0.01% 2137
2016
Q4
$200K Buy
+4,493
New +$200K 0.02% 629
2016
Q3
Sell
-7,105
Closed -$98K 4717
2016
Q2
$98K Buy
7,105
+5,813
+450% +$80.2K 0.01% 1118
2016
Q1
$25K Sell
1,292
-417
-24% -$8.07K ﹤0.01% 1204
2015
Q4
$60K Buy
+1,709
New +$60K 0.01% 475
2015
Q3
Sell
-368
Closed -$32K 5073
2015
Q2
$32K Sell
368
-740
-67% -$64.3K ﹤0.01% 1728
2015
Q1
$82K Buy
1,108
+1,071
+2,895% +$79.3K 0.01% 1057
2014
Q4
$2K Sell
37
-59
-61% -$3.19K ﹤0.01% 3429
2014
Q3
$4K Sell
96
-180
-65% -$7.5K ﹤0.01% 3490
2014
Q2
$11K Sell
276
-1,030
-79% -$41.1K ﹤0.01% 2301
2014
Q1
$90K Buy
1,306
+650
+99% +$44.8K 0.01% 766
2013
Q4
$40K Sell
656
-529
-45% -$32.3K 0.01% 1589
2013
Q3
$72K Buy
1,185
+35
+3% +$2.13K 0.01% 1598
2013
Q2
$77K Buy
+1,150
New +$77K 0.01% 644